Literature DB >> 17424079

Human recombinant erythropoietin therapy in a cat with chronic renal failure.

R M Bloomberg, H A Pook, R M Jacobs, J M Van Gorder.   

Abstract

Entities:  

Year:  1992        PMID： 17424079      PMCID： PMC1481339     

Source DB:  PubMed          Journal:  Can Vet J        ISSN： 0008-5286            Impact factor:   1.008


× No keyword cloud information.
  6 in total

1.  The bleeding disorder of uraemia. A qualitative platelet defect.

Authors:  P A Castaldi; M C Rozenberg; J H Stewart
Journal:  Lancet       Date:  1966-07-09       Impact factor: 79.321

2.  Haemolysis in chronic renal failure.

Authors:  A B Shaw
Journal:  Br Med J       Date:  1967-04-22

Review 3.  Treatment of the anemia of chronic renal failure with recombinant human erythropoietin.

Authors:  J W Adamson; J W Eschbach
Journal:  Annu Rev Med       Date:  1990       Impact factor: 13.739

4.  Review of patients' responses to epoetin alfa therapy.

Authors:  S B Krantz
Journal:  Pharmacotherapy       Date:  1990 Mar-Apr       Impact factor: 4.705

Review 5.  Guidelines for recombinant human erythropoietin therapy.

Authors:  J W Eschbach; J W Adamson
Journal:  Am J Kidney Dis       Date:  1989-08       Impact factor: 8.860

6.  Iron management during recombinant human erythropoietin therapy.

Authors:  D B Van Wyck
Journal:  Am J Kidney Dis       Date:  1989-08       Impact factor: 8.860
  6 in total
  2 in total

1.  Human recombinant erythropoietin used to treat a cat with anemia caused by chronic renal failure.

Authors:  P A Henry
Journal:  Can Vet J       Date:  1994-06       Impact factor: 1.008

2.  A lentiviral gene therapy strategy for the in vitro production of feline erythropoietin.

Authors:  Natalia Vapniarsky; Michael Lame; Samantha McDonnel; Brian Murphy
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.